Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Emtricitabine Rilpivirine Tenofovir Disoproxil Fumarate Atc J05Ar08 Obo For The Period From 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7166995

EMD:Ref Document

Bid Value: Ref Document

103 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

103 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 01 Sep 2026

Germany

Ref. No.: 7066220

EMD:Ref Document

Bid Value: Ref Document

161 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 07

Deadline: 05 Jul 2026

Germany

Ref. No.: 6913330

EMD:Ref Document

Bid Value: Ref Document

103 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Latanoprost Timolol Official Atc Code S01Ed61

Deadline: 30 Sep 2026

Germany

Ref. No.: 6841126

EMD:Ref Document

Bid Value: Ref Document

190 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Telmisartan Atc Code According To Who C09Ca07

Deadline: 30 Sep 2026

Germany

Ref. No.: 6839481

EMD:Ref Document

Bid Value: Ref Document

190 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan Atc Code G04Bx21

Deadline: 31 Aug 2026

Germany

Ref. No.: 6815091

EMD:Ref Document

Bid Value: Ref Document

160 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan Atc Code C03Xa01

Deadline: 31 Aug 2026

Germany

Ref. No.: 6804520

EMD:Ref Document

Bid Value: Ref Document

160 Days Left

Modernization Of Dhaka Central Drug De Addiction Centre Tejgaon Dhaka Sub Head External Electrification Works In C Submersible Pump Motor Set Lighting Protection Cctv System Pabx Intercom System Networking System Lan Wi Fi Pa Conferen

Deadline: 27 Dec 2026

Bangladesh

Ref. No.: 6733152

EMD:Ref Document

Bid Value: Ref Document

278 Days Left

Prostate Cancer Omics Oriented Intervention

Deadline: 31 Aug 2028

Germany

Ref. No.: 6732705

EMD:Ref Document

Bid Value: Ref Document

891 Days Left

Adtv Cctv Replacement

Deadline: 30 Sep 2029

Australia

Ref. No.: 6635589

EMD:Ref Document

Bid Value: Ref Document

1286 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Quinine

Deadline: 10 May 2026

Germany

Ref. No.: 6596413

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Clobazam

Deadline: 10 May 2026

Germany

Ref. No.: 6591825

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pilocarpine

Deadline: 10 May 2026

Germany

Ref. No.: 6590432

EMD:Ref Document

Bid Value: Ref Document

47 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For Ws Lanthanum Iii Carbonate In The Dosage Form Of Chewable Tablets Atc Code According To Who V0

Deadline: 31 Jul 2026

Germany

Ref. No.: 6417253

EMD:Ref Document

Bid Value: Ref Document

129 Days Left

Showing 20446 to 20460 of 20574 results

‹
1
2
...
1361
1362
1363
1364
1365
1366
1367
...
1371
1372
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!